Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: insights for psychosis treatment

Eur Neuropsychopharmacol. 2015 Apr;25(4):566-82. doi: 10.1016/j.euroneuro.2015.01.003. Epub 2015 Jan 15.

Abstract

Antipsychotics may modulate the transcription of multiple gene programs, including those belonging to postsynaptic density (PSD) network, within cortical and subcortical brain regions. Understanding which brain region is activated progressively by increasing doses of antipsychotics and how their different receptor profiles may impact such an activation could be relevant to better correlate the mechanism of action of antipsychotics both with their efficacy and side effects. We analyzed the differential topography of PSD transcripts by incremental doses of two antipsychotics: haloperidol, the prototypical first generation antipsychotic with prevalent dopamine D2 receptors antagonism, and asenapine, a second generation antipsychotic characterized by multiple receptors occupancy. We investigated the expression of PSD genes involved in synaptic plasticity and previously demonstrated to be modulated by antipsychotics: Homer1a, and its related interacting constitutive genes Homer1b/c and PSD95, as well as Arc, C-fos and Zif-268, also known to be induced by antipsychotics administration. We found that increasing acute doses of haloperidol induced immediate-early genes (IEGs) expression in different striatal areas, which were progressively recruited by incremental doses with a dorsal-to-ventral gradient of expression. Conversely, increasing acute asenapine doses progressively de-recruited IEGs expression in cortical areas and increased striatal genes signal intensity. These effects were mirrored by a progressive reduction in locomotor animal activity by haloperidol, and an opposite increase by asenapine. Thus, we demonstrated for the first time that antipsychotics may progressively recruit PSD-related IEGs expression in cortical and subcortical areas when administered at incremental doses and these effects may reflect a fine-tuned dose-dependent modulation of the PSD.

Keywords: Asenapine; Bipolar disorder; Haloperidol; Homer; Immediate-early genes; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • AIDS-Related Complex / genetics
  • AIDS-Related Complex / metabolism
  • Analysis of Variance
  • Animals
  • Antipsychotic Agents / pharmacology*
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cerebral Cortex / drug effects*
  • Cerebral Cortex / metabolism
  • Corpus Striatum / drug effects*
  • Corpus Striatum / metabolism
  • Disks Large Homolog 4 Protein
  • Dose-Response Relationship, Drug
  • Early Growth Response Protein 1 / genetics
  • Early Growth Response Protein 1 / metabolism
  • Gene Expression Regulation / drug effects
  • Homer Scaffolding Proteins
  • Intracellular Signaling Peptides and Proteins / genetics
  • Intracellular Signaling Peptides and Proteins / metabolism
  • Male
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Motor Activity / drug effects
  • Oncogene Proteins v-fos / genetics
  • Oncogene Proteins v-fos / metabolism
  • Post-Synaptic Density / drug effects*
  • Post-Synaptic Density / metabolism
  • Protein Binding / drug effects
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Statistics, Nonparametric

Substances

  • Antipsychotic Agents
  • Carrier Proteins
  • Disks Large Homolog 4 Protein
  • Dlg4 protein, rat
  • EGR1 protein, human
  • Early Growth Response Protein 1
  • Homer Scaffolding Proteins
  • Intracellular Signaling Peptides and Proteins
  • Membrane Proteins
  • Oncogene Proteins v-fos
  • RNA, Messenger